Observational Study Regarding the Necessity of Inclusion of Foot Arch State Together With the Angiosome Theory Within the Wound, Ischemia and Foot Infection Classification (WIfI) to Enhance the Predictability of Wound Healing and Decision Making
NCT ID: NCT06542523
Last Updated: 2024-08-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
60 participants
OBSERVATIONAL
2024-03-01
2025-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
C-myc Biomarker Study for Diabetic Foot Ulcers
NCT04591691
Wound Healing In Diabetes (WHy) Study
NCT01002521
Non-Invasive Testing to Evaluate Wound Healing in Diabetes
NCT04232631
Obtaining and Storing Standard of Care Wound Biopsies for Immediate or Future Wound-Related Scientific Study
NCT00759889
Impaired Wound Healing in Diabetic Foot Ulceration
NCT00739323
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Type 1: patent foot arch Type 2: partially occluded foot arch which is divided into whether Type 2a: patent dorsal tributary of foot arch Type 2b: patent lateral tributary of foot arch Type 3: totally occluded foot arch is divided into whether. Type 3a: totally occluded foot arch with anterior tibial artery inflow. Type 3b: totally occluded foot arch with posterior tibial artery inflow.
During follow-up assessments, wound is classified to be within: anterior tibial artery, posterior tibial artery or both territories.
Wound healing states are often classified based on the progression of the healing process into each of the following categories such as:
1. Complete Healing: Wound closure with the restoration of tissue integrity and absence of signs of infection.
2. Partial Healing: Significant improvement but not complete closure; may involve reduction in wound size and improved tissue viability.
3. Worsening: Increase in wound size or signs of infection which may necessitates performing major amputation.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
WIFI stage 1 with type 1 foot arch
No interventions assigned to this group
WIFI stage 2 with type 1 foot arch
No interventions assigned to this group
WIFI stage 3 with type 1 foot arch
No interventions assigned to this group
WIFI stage 1 with type 2a foot arch
No interventions assigned to this group
WIFI stage 2 with type 2a foot arch
No interventions assigned to this group
WIFI stage 3 with type 2a foot arch
No interventions assigned to this group
WIFI stage 1 with type 2b foot arch
No interventions assigned to this group
WIFI stage 2 with type 2b foot arch
No interventions assigned to this group
WIFI stage 3 with type 2b foot arch
No interventions assigned to this group
WIFI stage 1 with type 3a foot arch
No interventions assigned to this group
WIFI stage 2 with type 3a foot arch
No interventions assigned to this group
WIFI stage 3 with type 3a foot arch
No interventions assigned to this group
WIFI stage 1 with type 3b foot arch
No interventions assigned to this group
WIFI stage 2 with type 3b foot arch
No interventions assigned to this group
WIFI stage 3 with type 3b foot arch
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
2. Critically ill patients
3. Patients with acute ischemia
4. patients with pure venous ulcer
5. patients with ulcer due to rheumatological disease
6. The patient has known sensitivity to heparin.
7. The patient has comorbid conditions that may limit their ability to comply with the follow-up requirements
8. The patient has an untreatable allergy to radiographic contrast material.
9. Patient refusing consent
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ain Shams University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ain Shams University
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AinShamsUnivascular
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.